Evidence map›Paper›PMID 41528749›Full record

ArticleJAMA network open2026

Machine Learning-Guided Detection of Malignancy of Lung Nodules With Molecular Imaging-Guided Surgery.

Feredun Azari, Gregory T Kennedy, Andrew Hanna, Austin Chang, Ashley Chang, Bilal Nadeem, Azra Din, Edward Delikatny, John Kucharczuk, Sardar Azari and 1 more

Abstract read
In one paragraph

Article in JAMA network open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Feredun AzariDivision of Thoracic Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia.
Gregory T KennedyDivision of Thoracic Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia.
Andrew HannaUniversity of Pennsylvania Perelman School of Medicine, Philadelphia.
Austin ChangUniversity of Pennsylvania Perelman School of Medicine, Philadelphia.
Ashley ChangDivision of Thoracic Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia.
Bilal NadeemDivision of Thoracic Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia.
Azra DinDivision of Thoracic Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia.
Edward DelikatnyDepartment of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia.
John KucharczukDivision of Thoracic Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia.
Sardar AzariUniversity of Pennsylvania Perelman School of Medicine, Philadelphia.
Sunil SinghalDivision of Thoracic Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Over 1 million pulmonary nodules are discovered each year in the US, and many of these undergo molecular imaging-guided surgery to obtain a diagnosis. Locating a small nodule and determining its malignant potential is technically challenging and is prone to human error. Objective: To demonstrate use of a machine learning (ML) algorithm with molecular imaging to analyze imaging data during lung cancer surgery to determine malignant potential of nodules. Design, Setting, and Participants: Data were retrospectively analyzed from a prospectively collected database. Between 2014 and 2021, patients at the hospital of the University of Pennsylvania with lung nodules were included in the study. Patients in the model development set were randomly allocated into training and validation sets in an 8:2 ratio. Data were analyzed from January 2014 and December 2021. Main Outcomes and Measures: Algorithmic tumor to background ratio (TBR) detection was implemented for individual images using Image Processing Toolkit. Developed nomogram and artificial intelligence (AI) image analyzer were combined as an optical biopsy algorithm and tested prospectively between 2021 and 2024. Results: A total of 322 patients with lung nodules were included in the study, of whom 279 had complete clinical data for data analysis (175 [62.7%] female). The nomograms and image segmentation technology were developed using a large database of IMI videos (1014 video sequences) and demonstrated an area under the curve of 0.865 to 0.893 for malignant nodule assessment. On multivariate logistic regression analysis, patient smoking history of greater than 5 pack-years (patient pack-years [PPY] >5), ex vivo back table TBR greater than 2.0, ex vivo bisected tumor lesions TBR greater than 2.4, and in situ (inside the chest) fluorescence were found to have statistically significant associations with malignancy on final pathology. Prospective testing in an independent set of 61 consecutive patients during IMI-guided cancer surgery demonstrated a sensitivity of 93.8%, specificity of 100%, positive predictive value of 100%, and negative predictive value of 71%. The study algorithm determined malignant potential of the lesion in less than 2 minutes (mean [SD], 1.8 [0.17] minutes) compared with a mean (SD) of 34 (11) minutes with frozen section analysis. Conclusion: In this cohort study of patients with indeterminate lung nodules, intraoperative imaging data analyzed by AI accurately determined if a nodule was malignant. This has the potential to improve the diagnostic challenges that occur at the time of surgery.

Indexed as

Lung NeoplasmsMachine LearningMolecular ImagingSolitary Pulmonary NoduleSurgery, Computer-AssistedAgedAlgorithmsFemaleHumansMaleMiddle AgedRetrospective Studies

Identifiers

PMID41528749
PMCPMC12801086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.